4.5 Article

Autocrine release of TGF-β by portal fibroblasts regulates cell growth

Journal

FEBS LETTERS
Volume 559, Issue 1-3, Pages 107-110

Publisher

ELSEVIER SCIENCE BV
DOI: 10.1016/S0014-5793(04)00037-7

Keywords

transforming growth factor-beta; transforming growth factor-beta receptor; betaglycan; fibrosis; biliary cirrhosis; portal fibroblast

Funding

  1. NIDDK NIH HHS [P30-DK-50306, DK 34989, K08-DK02379, R01-DK58123] Funding Source: Medline

Ask authors/readers for more resources

Portal fibroblasts (PF) are a newly isolated population of fibrogenic cells in the liver postulated to play a significant role in early biliary fibrosis. Because transforming growth factor-beta (TGF)-beta is a key growth factor in fibrosis, we characterized the response of PF to TGF-beta. We demonstrate that PF produce significant amounts of TGF-beta2 and, unlike activated hepatic stellate cells (HSC), express all three TGF-beta receptors and are growth inhibited by TGF-beta1 and TGF-beta2. Fibroblast growth factor (FGF)-2, but not platelet derived growth factor (PDGF), causes PF proliferation. These data suggest a mechanism whereby HSC eclipse PF as the dominant myofibroblast population in biliary fibrosis. (C) 2004 Federation of European Biochemical Societies. Published by Elsevier B.V. All rights reserved.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available